PlainRecalls
FDA Drug Moderate Class II Ongoing

Phytonadione Injectable Emulsion, USP 10mg/mL, 10x1 mL Single-Dose Vial/carton, Rx Only, Mfd. by: Cipla Ltd. India At M/s Immacule Lifesciences PVT. Ltd. India. Mfd. for: Cipla USA, Inc. Warren, NJ 07059. Vial NDC# 69097-708-31; Carton NDC 69097-708-96

Reported: December 10, 2025 Initiated: October 31, 2025 #D-0197-2026

Product Description

Phytonadione Injectable Emulsion, USP 10mg/mL, 10x1 mL Single-Dose Vial/carton, Rx Only, Mfd. by: Cipla Ltd. India At M/s Immacule Lifesciences PVT. Ltd. India. Mfd. for: Cipla USA, Inc. Warren, NJ 07059. Vial NDC# 69097-708-31; Carton NDC 69097-708-96

Reason for Recall

Failed Stability Specifications: Observed OOS results: eg results for colour index

Details

Recalling Firm
Cipla Limited
Units Affected
4,438 10x1mL cartons
Distribution
Nationwide in the USA
Location
Pithampur, District Dhar

Frequently Asked Questions

What product was recalled?
Phytonadione Injectable Emulsion, USP 10mg/mL, 10x1 mL Single-Dose Vial/carton, Rx Only, Mfd. by: Cipla Ltd. India At M/s Immacule Lifesciences PVT. Ltd. India. Mfd. for: Cipla USA, Inc. Warren, NJ 07059. Vial NDC# 69097-708-31; Carton NDC 69097-708-96. Recalled by Cipla Limited. Units affected: 4,438 10x1mL cartons.
Why was this product recalled?
Failed Stability Specifications: Observed OOS results: eg results for colour index
Which agency issued this recall?
This recall was issued by the FDA Drug on December 10, 2025. Severity: Moderate. Recall number: D-0197-2026.